Exploring Sanofi's Revamped IO Pipeline

 
• By Lucie Ellis-Taitt

In an exclusive interview, Sanofi's head of oncology development Joanne Lager explains how the French big pharma could make a comeback in cancer this year and highlights its immunotherapy combination opportunities.

Butterfly
Sanofi's oncology portfolio to transform in 2018 • Source: Shutterstock

More from Strategy

More from Business